| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 732827 | 86571 | PAZOPANIB STADA 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | PAZOPANIB STADA 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 200 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86571/86571_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86571/86571_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2022-02-21 | 1 | 1 | 1 | 2022-02-22 | 2022-02-21 | 1 | 2025-11-04 | View Edit Delete | ||||||||||||
| 732829 | 86572 | PAZOPANIB STADA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | PAZOPANIB STADA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 400 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86572/86572_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86572/86572_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2022-02-21 | 1 | 1 | 1 | 2022-02-22 | 2022-02-21 | 1 | 2025-11-04 | View Edit Delete | ||||||||||||
| 763174 | 88986 | IBEROGAST ELEMENTAL GOTAS ORALES EN SOLUCION | IBEROGAST ELEMENTAL GOTAS ORALES EN SOLUCION, 1 frasco de 20 ml | N/A (más de 4 PA) | 6 | 20 | 26 | 1 frasco de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88986/88986_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88986/88986_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 2024-07-22 | 1 | 1 | 1 | 2024-07-22 | 2024-07-22 | 1 | 2025-11-04 | View Edit Delete | ||||||||||||
| 763175 | 88986 | IBEROGAST ELEMENTAL GOTAS ORALES EN SOLUCION | IBEROGAST ELEMENTAL GOTAS ORALES EN SOLUCION, 1 frasco de 50 ml | N/A (más de 4 PA) | 6 | 50 | 26 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88986/88986_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88986/88986_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 2024-07-22 | 1 | 1 | 1 | 2024-07-22 | 2024-07-22 | 1 | 2025-11-04 | View Edit Delete | ||||||||||||
| 765386 | 89711 | DEXKETOPROFENO AUROVITAS PHARMA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA | DEXKETOPROFENO AUROVITAS PHARMA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA, 10 comprimidos | 25 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89711/89711_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89711/89711_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2024-07-15 | 1 | 1 | 1 | 2024-07-16 | 2024-07-15 | 1 | 2025-11-03 | View Edit Delete | ||||||||||||
| 767019 | 90166 | ATORVASTATINA COMBIX PHARMA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORVASTATINA COMBIX PHARMA 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90166/90166_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90166/90166_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2025-02-24 | 1 | 1 | 1 | 2025-02-25 | 2025-02-24 | 1 | 2025-11-03 | View Edit Delete | ||||||||||||
| 767023 | 90168 | ATORVASTATINA COMBIX PHARMA 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ATORVASTATINA COMBIX PHARMA 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 60 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90168/90168_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90168/90168_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2025-02-24 | 1 | 1 | 1 | 2025-02-25 | 2025-02-24 | 1 | 2025-11-03 | View Edit Delete | ||||||||||||
| 766719 | 90078 | AZERIX 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL | AZERIX 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL, 1 frasco de 23 g (120 aplicaciones) | 50 microgramos/137 microgramos/dosis | 6 | 120 | 31 | 1 frasco de 23 g (120 aplicaciones) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90078/90078_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90078/90078_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 587 | ESPECIALIDADES FARMACEUTICAS CENTRUM S.A. | 2025-01-20 | 1 | 1 | 1 | 2025-01-21 | 2025-01-20 | 1 | 2025-11-03 | View Edit Delete | ||||||||||||
| 765899 | 1241851002 | ANZUPGO 20 MG/G CREMA | ANZUPGO 20 MG/G CREMA, 1 tubo de 60 g | 20 mg/g | 44 | 60 | 21 | 1 tubo de 60 g | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241851002/1241851002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241851002/1241851002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 8764 | LABORATORIOS LEO PHARMA S.A. | 2024-10-03 | 1 | 1 | 1 | 2024-10-04 | 2024-10-03 | 1 | 2025-11-03 | View Edit Delete | ||||||||||||
| 767426 | 90265 | ATORVASTATINA/EZETIMIBA CINFA 20 MG/10 MG CAPSULAS DURAS | ATORVASTATINA/EZETIMIBA CINFA 20 MG/10 MG CAPSULAS DURAS, 30 cápsulas | 20 mg/10 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90265/90265_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90265/90265_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2025-04-09 | 1 | 1 | 1 | 2025-04-10 | 2025-04-09 | 1 | 2025-11-03 | View Edit Delete | ||||||||||||
| 767427 | 90266 | ATORVASTATINA/EZETIMIBA CINFA 40 MG/10 MG CAPSULAS DURAS | ATORVASTATINA/EZETIMIBA CINFA 40 MG/10 MG CAPSULAS DURAS, 30 cápsulas | 40 mg/10 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90266/90266_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90266/90266_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2025-04-09 | 1 | 1 | 1 | 2025-04-10 | 2025-04-09 | 1 | 2025-11-03 | View Edit Delete | ||||||||||||
| 728952 | 75243 | EFFERALDOL 1 G COMPRIMIDOS | EFFERALDOL 1 G COMPRIMIDOS, 10 comprimidos (blister) | 1.000 mg | 5 | 10 | 10 | 10 comprimidos (blister) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75243/75243_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75243/75243_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16744 | NEWLINE PHARMA S.L.U. | 2012-01-10 | 1 | 1 | 1 | 2012-01-10 | 2020-07-15 | 0 | 2025-10-31 | View Edit Delete | ||||||||||||
| 733012 | 86627 | EFFERALDOL 650 MG COMPRIMIDOS | EFFERALDOL 650 MG COMPRIMIDOS, 20 comprimidos | 650 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86627/86627_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86627/86627_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16744 | NEWLINE PHARMA S.L.U. | 2022-03-16 | 1 | 1 | 1 | 2022-03-17 | 2022-03-16 | 0 | 2025-10-31 | View Edit Delete | ||||||||||||
| 767965 | 1241863004 | OTULFI 45 MG SOLUCIÓN INYECTABLE | OTULFI 45 MG SOLUCIÓN INYECTABLE, 1 vial de 0,5 ml | 45 mg inyectable 0,5 ml | 45 | 1 | 34 | 1 vial de 0,5 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1241863004/1241863004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1241863004/1241863004_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1097 | FRESENIUS KABI ESPAÑA, S.A.U. | 2025-06-16 | 1 | 1 | 1 | 2025-06-17 | 2025-06-16 | 1 | 2025-10-31 | View Edit Delete | ||||||||||||
| 768324 | 1201497001IP1 | PHESGO 1200 MG/600 MG SOLUCION INYECTABLE | PHESGO 1200 MG/600 MG SOLUCION INYECTABLE, 1 vial de 15 ml | 1200 mg/600 mg inyectable 15 ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201497001IP1/1201497001IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201497001IP1/1201497001IP1_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ORIFARM A/S | 2025-08-28 | 1 | 1 | 1 | 2025-08-29 | 2025-08-28 | 1 | 2025-10-31 | View Edit Delete | ||||||||||||
| 768285 | 1211538001IP | JEMPERLI 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | JEMPERLI 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 500 mg inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211538001IP/1211538001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211538001IP/1211538001IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30289 | ABACUS MEDICINE A/S | 2025-08-08 | 1 | 1 | 1 | 2025-08-09 | 2025-08-08 | 1 | 2025-10-30 | View Edit Delete | ||||||||||||
| 768859 | 98086024IP5 | COAPROVEL 300 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | COAPROVEL 300 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 300 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98086024IP5/98086024IP5_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98086024IP5/98086024IP5_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41749 | ABACUS MEDICINE A/S | 2025-10-21 | 1 | 1 | 1 | 2025-10-22 | 2025-10-21 | 1 | 2025-10-30 | View Edit Delete | ||||||||||||
| 731533 | 86172 | COHORTAN 5 MG/G + 5 MG/G POMADA RECTAL | COHORTAN 5 MG/G + 5 MG/G POMADA RECTAL, 1 tubo de 30 g | 5 mg/g + 5 mg/g | 44 | 30 | 21 | 1 tubo de 30 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86172/86172_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86172/86172_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2021-08-23 | 1 | 1 | 1 | 2021-08-24 | 2021-08-23 | 0 | 2025-10-29 | View Edit Delete | ||||||||||||
| 768547 | 113882002IP2 | ABILIFY MAINTENA 400 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | ABILIFY MAINTENA 400 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial + 1 vial de disolvente | 400 mg | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113882002IP2/113882002IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113882002IP2/113882002IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | ECOFAR PRODUCTOS S.L. | 2025-09-24 | 1 | 1 | 1 | 2025-09-25 | 2025-09-24 | 1 | 2025-10-29 | View Edit Delete | ||||||||||||
| 766696 | 08463003 | RELISTOR 12 mg/0,6 ml, SOLUCION INYECTABLE | RELISTOR 12 mg/0,6 ml, SOLUCION INYECTABLE, 7 viales + 7 jeringas precargadas + aguja con protector de seguridad | 12 mg inyectable 0,6 ml | 80 | 7 | 34 | 7 viales + 7 jeringas precargadas + aguja con protector de seguridad | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08463003/08463003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08463003/08463003_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30213 | ZENTIVA SPAIN S.L. | 2008-07-15 | 1 | 1 | 1 | 2008-07-15 | 2025-01-14 | 1 | 2025-10-24 | View Edit Delete |
Page 47 of 1036, showing 20 records out of 20704 total, starting on record 921, ending on 940